The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college students

Jay R Hoffman, Nicholas A Ratamess, Adam Gonzalez, Noah A Beller, Mattan W Hoffman, Mark Olson, Martin Purpura, Ralf Jäger, Jay R Hoffman, Nicholas A Ratamess, Adam Gonzalez, Noah A Beller, Mattan W Hoffman, Mark Olson, Martin Purpura, Ralf Jäger

Abstract

Background: The purpose of this study was to examine the effect of acute and prolonged (4-weeks) ingestion of a supplement designed to improve reaction time and subjective measures of alertness, energy, fatigue, and focus compared to placebo.

Methods: Nineteen physically-active subjects (17 men and 2 women) were randomly assigned to a group that either consumed a supplement (21.1 ± 0.6 years; body mass: 80.6 ± 9.4 kg) or placebo (21.3 ± 0.8 years; body mass: 83.4 ± 18.5 kg). During the initial testing session (T1), subjects were provided 1.5 g of the supplement (CRAM; α-glycerophosphocholine, choline bitartrate, phosphatidylserine, vitamins B3, B6, and B12, folic acid, L-tyrosine, anhydrous caffeine, acetyl-L-carnitine, and naringin) or a placebo (PL), and rested quietly for 10-minutes before completing a questionnaire on subjective feelings of energy, fatigue, alertness and focus (PRE). Subjects then performed a 4-minute quickness and reaction test followed by a 10-min bout of exhaustive exercise. The questionnaire and reaction testing sequence was then repeated (POST). Subjects reported back to the lab (T2) following 4-weeks of supplementation and repeated the testing sequence.

Results: Reaction time significantly declined (p = 0.050) between PRE and POST at T1 in subjects consuming PL, while subjects under CRAM supplementation were able to maintain (p = 0.114) their performance. Significant performance declines were seen in both groups from PRE to POST at T2. Elevations in fatigue were seen for CRAM at both T1 and T2 (p = 0.001 and p = 0.000, respectively), but only at T2 for PL (p = 0.029). Subjects in CRAM maintained focus between PRE and POST during both T1 and T2 trials (p = 0.152 and p = 0.082, respectively), whereas significant declines in focus were observed between PRE and POST in PL at both trials (p = 0.037 and p = 0.014, respectively). No difference in alertness was seen at T1 between PRE and POST for CRAM (p = 0.083), but a significant decline was recorded at T2 (p = 0.005). Alertness was significantly lower at POST at both T1 and T2 for PL (p = 0.040 and p = 0.33, respectively). No differences in any of these subjective measures were seen between the groups at any time point.

Conclusion: Results indicate that acute ingestion of CRAM can maintain reaction time, and subjective feelings of focus and alertness to both visual and auditory stimuli in healthy college students following exhaustive exercise. However, some habituation may occur following 4-weeks of supplementation.

Figures

Figure 1
Figure 1
Testing Session.
Figure 2
Figure 2
Acute and Prolonged Effects of αGPC supplementation on Reaction Performance. * = significantly different that Pre.
Figure 3
Figure 3
Subjective Feelings of Energy. * = significantly different that Pre.
Figure 4
Figure 4
Subjective Feelings of Fatigue. * = significantly different that Pre.
Figure 5
Figure 5
Subjective Feelings of Focus. * = significantly different that Pre.
Figure 6
Figure 6
Subjective Feelings of Alertness. * = significantly different that Pre.

References

    1. Jäger R, Purpura M, Kingsley M. Phospholipids and sports performance. J Int Soc Sports Nutr. 2007;4:5.
    1. Amenta F, Tayebati SK. Pathwasy of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. Curr Med Chem. 2008;15:488–498. doi: 10.2174/092986708783503203.
    1. Buchman AL, Sohel M, Brown M, Jenden DJ, Ahn C, Roch M, Brawley TL. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study. J Parenter Enteral Nutr. 2001;25:30–35. doi: 10.1177/014860710102500130.
    1. Canal N, Franceschi M, Alberoni M, Castiglioni C, De Moliner P, Longoni A. Effect of L-alpha-glyceryl-phoshorylcholine on amnesia caused by scopolamine. Int J Clin Pharmacol Ther Toxicol. 1991;29:103–107.
    1. DiPerri R, Coppola G, Ambrosio LA, Grasso A, Puca FM, Rizzo M. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cystosine diphosphocholine in patients with vascular dementia. J Int Med Res. 1991;19:330–341.
    1. Gossell-Williams M, Simon O, Young L, West M. Choline supplementation facilitates short-term memory consolidation into intermediate long-term memory of young Sprague-Dawley rats. West Indian Med J. 2006;55:4–8.
    1. Conlay LA, Wurtman RJ, Blusztajn JK, Coviella ILG, Maher TJ, Evoniuk GE. Decreased plasma choline concentrations in marathon runners. N Engl J Med. 1986;315:892.
    1. Penry JT, Manore MM. Choline: an important micronutrient for maximal endurance-exercise performance? Int J Sport Nutr Exerc Metab. 2008;18:191–203.
    1. Deuster PA, Singh A, Coll R, Hyde DE, Becker WJ. Choline ingestion does not modify physical or cognitive performance. Mil Med. 2002;167:1020–1025.
    1. Warber JP, Patton JF, Tharion WJ, Zeisel SH, Mello RP, Kemnitz CP, Lieberman HR. The effects of choline supplementation on physical performance. Int J Sport Nutr Exerc Metab. 2000;10:170–181.
    1. Hirsch MJ, Growdon JH, Wurtman RJ. Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism. 1978;27:953–960. doi: 10.1016/0026-0495(78)90139-7.
    1. Wurtman RJ, Hirsch MJ, Growdon JH. Lecithin consumption raises serum-free-choline levels. Lancet. 1977;2:68–69. doi: 10.1016/S0140-6736(77)90067-8.
    1. Ziegenfuss T, Landis J, Hofheins J. Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. J Int Soc Sports Nutr. 2008;5(Suppl 1):P15. doi: 10.1186/1550-2783-5-S1-P15.
    1. Blokland A, Honig W, Browns F, Jolles J. Cognition-enhancing properties of subchronic phosphatidylserine (ps) treatment in middle-aged rats: comparision of bovine cortex ps with eggs ps and soybean ps. Nutrition. 1999;15:778–783. doi: 10.1016/S0899-9007(99)00157-4.
    1. Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R. The effects of phosphotidylserine on endocrine response to moderate intensity exercise. J Inter Soc Sports Nutr. 2008;5:11. doi: 10.1186/1550-2783-5-11.
    1. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes tgf-β1 secretion and the resolution of inflammation. J Clin Invest. 2002;109:41–50.
    1. Monteleone P, Beinat L, Tanzillo C, Maj M, Kemall D. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology. 1990;52:243–248. doi: 10.1159/000125593.
    1. Dacaranhe CD, Terao J. A unique antioxidant activity of phosphatidylserine on iron-induced lipid peroxidation of phospholipid bilayers. Lipids. 2001;36:1105–1110. doi: 10.1007/s11745-001-0820-7.
    1. Lactorraca S, Piersanti P, Tesco G, Piacentini S, Amaducci L, Sorbi S. Effect of phosphatidylserine on free radical susceptibility in human diploid fibroblasts. J Neural Transm Park Dis Dement Sect. 1993;6:73–77. doi: 10.1007/BF02252625.
    1. Kingsley M, Wadsworth D, Kilduff LP, McEneny J, Benton D. Effects of phosphatidylserine on oxidative stress following intermittent running. Med Sci Sports Exerc. 2005;37:1300–1306. doi: 10.1249/01.mss.0000175306.05465.7e.
    1. Kingsley M, Miller M, Kilduff LP, McEneny J, Benton D. Effects of phosphatidylserine on exercise capacity during cycling in active males. Med Sci Sports Exerc. 2006;38:64–71. doi: 10.1249/01.mss.0000183195.10867.d0.
    1. Kingsley M, Kilduff LP, McEneny J, Dietzig R, Benton D. Phosphatidylserine supplementation and recovery following downhill running. Med Sci Sports Exerc. 2006;38:1617–1625. doi: 10.1249/01.mss.0000183195.10867.d0.
    1. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36:291–298. doi: 10.1016/0165-1781(91)90027-M.
    1. Haubrich DR, Wang PFL, Clody DE, Wedeking PW. Increase in rat brain acetylcholine induced by choline or deanol. Life Sci. 1975;17:975–980. doi: 10.1016/0024-3205(75)90451-8.
    1. Trammer BA, Schmidt DE, Wecker L. Exogenous choline enhances the synthesis of acetylcholine only under conditions of increased cholinergic neuronal activity. J Neurochem. 1982;39:1704–1709. doi: 10.1111/j.1471-4159.1982.tb08006.x.
    1. Spector SA, Jackman MR, Sabounjian LA, Sakkas C, Landers DM, Willis WT. Effect of choline supplementation on fatigue in trained cyclists. Med Sci Sports Exerc. 1995;27:668–673.
    1. Conlay LA, Sabounjian LA, Wurtman RJ. Exercise and neuromodulators: choline and acetylcholine in marathon runners. Int J Sports Med. 1992;13:S141–S142. doi: 10.1055/s-2007-1024619.
    1. Van Allworden HN, Horn S, Kahl J, Feldheim W. The influence of lecithin on plasma choline concentrations in triathletes and adolescent runners during exercise. Eur J Appl Physiol. 1993;67:87–91. doi: 10.1007/BF00377711.
    1. Moreno MDJM. Cognitive improvement in mild to moderate alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003;25:178–193. doi: 10.1016/S0149-2918(03)90023-3.
    1. Benton D, Donohoe RT, Silance B, Nabb S. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutr Neurosci. 2001;4:169–178.
    1. Jäger R, Purpura M, Geiss KR, Weiß M, Baumeister J, Amatulli F, Schröder L, Herwegen H. The effect of phosphatidylserine on golf performance. J Int Soc Sports Nutr. 2007;4:23.
    1. Kraemer WJ, Volek JS, French DN, Rubin MR, Sharman MJ, Gómez AL, Ratamess NA, Newton RU, Jemiolo B, Craig BW, Häkkinen K. The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery. J Strength Cond Res. 2003;17:455–462.
    1. Volek JS, Kraemer WJ, Rubin MR, Gómez AL, Ratamess NA, Gaynor P. L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab. 2002;282:E474–482.
    1. Hoffman JR. Caffeine and Energy Drinks. Strength and Cond J. 2010;12:15–20. doi: 10.1519/SSC.0b013e3181bdafa0.
    1. Sachan DS, Hongu N. Increases in VO2max and metabolic markers of fat oxidation by caffeine, carnitine, and choline supplementation in rats. J Nutr Biochem. 2000;11:521–526. doi: 10.1016/S0955-2863(00)00119-4.
    1. Suchy J, Chan A, Shea TB. Dietary supplementation with a combination of α-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res. 2009;29:70–74. doi: 10.1016/j.nutres.2008.11.004.
    1. Kidd PM. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005;10:268–293.
    1. Dhitavat S, Ortiz D, Shea TB, Rivera ER. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res. 2002;27:501–505. doi: 10.1023/A:1019800703683.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj